Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical industry continuously seeks novel molecular scaffolds and intermediates to synthesize new therapeutic agents. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in this ecosystem by supplying specialized chemicals, including phthalimide derivatives like N-(8-Hydroxyoctyl)phthalimide (CAS: 105264-63-9), which are instrumental in drug discovery and development.
Phthalimide derivatives have a long-standing history in medicinal chemistry. The phthalimide structure itself is a core component of several known pharmaceuticals, notably thalidomide and its analogues, which have significant applications in treating certain medical conditions. This established biological relevance makes phthalimide-based intermediates highly sought after for the synthesis of new drug candidates. N-(8-Hydroxyoctyl)phthalimide, with its specific structure, offers a unique pathway for chemists to explore.
N-(8-Hydroxyoctyl)phthalimide, characterized by its molecular formula C16H21NO3 and molecular weight of 275.348 g/mol, provides researchers with a compound that can be readily modified. The phthalimide nitrogen can be functionalized, and the terminal hydroxyl group on the octyl chain offers a reactive handle for further chemical transformations. This dual reactivity allows for the introduction of diverse pharmacophores or linking groups, which are essential steps in designing molecules with targeted biological activity.
Its role as a pharmaceutical intermediate is significant. By utilizing N-(8-Hydroxyoctyl)phthalimide, chemists can streamline the synthesis of complex molecules that may exhibit therapeutic effects. For example, the compound can be a precursor for creating analogues of existing drugs or for developing entirely new classes of therapeutic agents. The high purity (≥98.0%) of the material supplied by NINGBO INNO PHARMCHEM CO.,LTD. ensures that synthetic pathways are efficient and that the final drug products meet stringent quality standards.
The exploration of N-(8-Hydroxyoctyl)phthalimide in pharmaceutical research is an ongoing process. Scientists are investigating its potential in various therapeutic areas, leveraging its structure to synthesize compounds that could act as anti-inflammatory agents, enzyme inhibitors, or modulators of specific biological pathways. The versatility of this intermediate makes it a valuable tool for medicinal chemists aiming to discover and develop the next generation of pharmaceuticals.
NINGBO INNO PHARMCHEM CO.,LTD. is proud to support the pharmaceutical research community by providing access to high-quality intermediates like N-(8-Hydroxyoctyl)phthalimide, contributing to the advancement of healthcare through chemical innovation.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
